The race to offer H1N1 flu vaccination is picking up pace. While global H1N1 vaccine manufacturers like Sanofi Pasteur, Novartis and MedImmune have begun shipping their products, Indian vaccine majors Serum Institute of India, Panacea Biotech and Bharat Biotech are likely to start human clinical trials by the year-end and the H1N1 vaccine will hit the market by March-April next year.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Vaccines are Hot
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account